APA (7th ed.) Citation

Sobin, F. V., Pulina, N. A., & Novikova, V. V. (2022). Study of Antifungal Activity of Experimental Soft Dosage Form Based on the Hydrazone Derivative of Getarylamide 4-phenyl-2-hydroxy-4-oxo-2-butenoic acid. LLC Center of Pharmaceutical Analytics (LLC «CPHA»).

Chicago Style (17th ed.) Citation

Sobin, F. V., N. A. Pulina, and V. V. Novikova. Study of Antifungal Activity of Experimental Soft Dosage Form Based on the Hydrazone Derivative of Getarylamide 4-phenyl-2-hydroxy-4-oxo-2-butenoic Acid. LLC Center of Pharmaceutical Analytics (LLC «CPHA»), 2022.

MLA (9th ed.) Citation

Sobin, F. V., et al. Study of Antifungal Activity of Experimental Soft Dosage Form Based on the Hydrazone Derivative of Getarylamide 4-phenyl-2-hydroxy-4-oxo-2-butenoic Acid. LLC Center of Pharmaceutical Analytics (LLC «CPHA»), 2022.